Developing new vaccines for infectious diseases
Task V03: Product Development Plans
This study is all about developing and improving new vaccines to help fight infectious diseases, making sure they meet safety standards so they can be approved for use and ultimately help keep everyone healthier.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10390262 on NIH RePORTER |
What this research studies
This research focuses on creating and optimizing new vaccines and biologics to combat infectious diseases. It involves planning product development, conducting feasibility assessments, and ensuring compliance with manufacturing standards for clinical studies. The project also includes technical audits and regulatory support to facilitate the submission of new vaccines to the U.S. Food and Drug Administration (FDA). By advancing vaccine technology, this research aims to improve public health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of infectious diseases who may benefit from new vaccine options.
Not a fit: Patients who are not at risk for infectious diseases or those who have already been vaccinated against the targeted pathogens may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect against various infectious diseases.
How similar studies have performed: Previous research has shown success in developing vaccines using similar methodologies, indicating a promising potential for this approach.
Where this research is happening
New York, United States
- International AIDS Vaccine Initiative — New York, United States (Active)
Researchers
- Principal investigator: Hassell, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassell, Thomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.